Light for Sight is uniting clinical institutions, research groups, patient organizations and the private sector, with a single focus: to eliminate severe visual impairment among all children and adolescents with keratoconus.
Light for Sight is uniting clinical institutions, research groups, patient organizations and the private sector, with a single focus: to eliminate severe visual impairment among all children and adolescents with keratoconus.
Our flagship program is “Light for Sight 21”, which aims to reduce severe visual impairment among children and adolescents with Down Syndrome – who have a very high prevalence of the disease.
Individualized corneal cross-linking with riboflavin and UV-A in ultra-thin corneas: the sub400 protocol
Outreach: To promote awareness among patient groups (and families)
Education: To improve (vision) healthcare professional awareness
Access: Provide access to diagnosing and treatment of corneal diseases
Partners: To create a network of screening/treatment referral sites
Financing: To provide medical coverage for at-need patients
Research: To investigate, understand and treat the cause of keratoconus
During the Croatian Organisation of Cataract and Refractive Surgery (CROCS) 2023 annual meeting held in Zadar, Croatia, on 12th and 13th October, Prof. Farhad Hafezi lectured on “CXL in 2023” and he and ELZA’s CEO, Nikki Hafezi, performed Croatia’s largest keratoconus in Down Syndrome screening event to date.
Free screening. But why? Free. Gratis. Kostenlos. Light for Sight’s
January 29, Zurich, Switzerland Today, the Light for Sight foundation
Emilio, Riccardo and Bernardo got together during the 2018 CXL
Emilio and Federik got together during the 2018 CXL Experts’
Want to stay informed about our latest news, posts and articles?
© 2023 | Light for Sight Foundation | All rights reserved
![http://www.mazensinjab.com](https://www.vryghem.eu/>www.vryghem.be</a></p><div class="mpfy-mll-l-buttons"> <a href="#" data-mapify-action="openPopup" data-mapify-value="13579">More Details</a></div></div></div><div class="mpfy-mll-location" data-id="13724" data-order="51"><div class="mpfy-mll-l-heading"><div class="lazyload mpfy-mll-l-pin" data-bg="https://lightforsight.org/wp-content/plugins/mapifypro-master/assets/images/google-pin.png" style="background-image: url(data:image/svg+xml,%3Csvg%20xmlns=%22http://www.w3.org/2000/svg%22%20viewBox=%220%200%20500%20300%22%3E%3C/svg%3E);"></div><div class="mpfy-mll-l-title"> <span> Syria, Damascus, Al Zahra Medical Group </span> <span class="mpfy-mll-l-categories"> <a href="#" data-mapify-map-id="13397" data-mapify-action="setMapTag" data-mapify-value="59">Middle East</a> </span></div></div><div class="mpfy-mll-l-content"><p>Al Zahra Medical Group<br /> Mazen Sinjab, MD PhD<br /> Damascus<br /> Syria<br /> <b>Phone: </b><a href="tel:">+973 3674 7017</a><br /> <b>Email: </b><a href="mailto:mazen.sinjab@yahoo.com">mazen.sinjab@yahoo.com</a><br /> <b>Website: </b><a href="http://http://www.mazensinjab.com){kind=link}